Screener
BioCryst Pharmaceuticals BCRX Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's gross profit?
- BioCryst Pharmaceuticals (BCRX) reported gross profit of $214.41M in Q2 2026.
- How has BioCryst Pharmaceuticals's gross profit changed year-over-year?
- BioCryst Pharmaceuticals's gross profit increased by 33.5% year-over-year, from $160.56M to $214.41M.
- What is the long-term trend for BioCryst Pharmaceuticals's gross profit?
- Over 4 years (2021 to 2025), BioCryst Pharmaceuticals's gross profit has grown at a 54.6% compound annual growth rate (CAGR), from $149.94M to $855.76M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about BioCryst Pharmaceuticals's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude